Epstein Secrets

nd to that end I'd be happy to meet with you in Seattle (or elsewhere) if that would be desirable and would facilitate a discussion. Best regards, Ryan Ryan M. Schwarz Managing Director THE CARLYLE GROUP From: Boris Nikolic [mallto: Sent: Friday, March 11, 2011 2:21 AM To: Ryan Schwarz Subject

n the eventual fund placement memo and presentation. The other is a confidential summary of an investment opportunity that we are pursuing involving Xigris, the sole approved, on-market drug for severe sepsis. I look forward to seeing you in the morning. Ryan Ryan M. Schwarz Managing Director THE C

and to that end • be happy to meet with you in Seattle (or elsewhere) if that would be desirable and would facilitate a discussion. Best regards, Ryan Ryan M. Schwarz Managing Director THE CARLYLE GROUP 1001 Pennsylvania Ave. =. Washington, DC 20004 direct mobile From: Boris Nikolic [mailto:

n the eventual fund placement memo and presentation. The other is a confidential summary of an investment opportunity that we are pursuing involving Xigris, the sole approved, on-market drug for severe sepsis. I look forward to seeing you in the morning. Ryan Ryan M. Schwarz Managing Director THE C

portunity that we are pursuing involving Xigris, the sole approved, on-market drug for severe sepsis. I look forward to seeing you in the morning. Ryan Ryan M. Schwarz Managing Director THE CARLYLE GROUP 1001 Pennsylvania Ave. =. Washington, DC 20004 202-347-2626 202-347-1818 fax 202-729-5334

n the eventual fund placement memo and presentation. The other is a confidential summary of an investment opportunity that we are pursuing involving Xigris, the sole approved, on-market drug for severe sepsis. I look forward to seeing you in the morning. Ryan Ryan M. Schwarz Managing Director THE C